Comparing the original and biosimilar biotherapeutics of the monoclonal antibody eculizumab by intact mass measurement and middle-up mass spectrometry analysis by M. B. Degterev, R. R. Shukurov

Get full text

Development and validation of a peptide-mapping procedure for a novel C1 esterase inhibitor by E. V. Zubareva, M. D. Degterev, M. Yu. Neronova, M. A. Smolov, R. R. Shukurov

Get full text

Validation of a test procedure for determination of specific activity of human recombinant interferon beta (Infibeta®) using various cell/virus combinations by Yu. N. Lebedeva, N. A. Litvinova, T. N. Lobanova, R. R. Shukurov, R. A. Khamitov, L. A. Gaiderova

Get full text

Development and validation of an analytical procedure for the determination of residual protein A in active substances of therapeutic monoclonal antibodies by E. V. Nozdrina, D. A. Mazalev, D. R. Rogozina, S. P. Zhivoderov, I. V. Lyagoskin, R. R. Shukurov

Get full text

Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products by V. D. Gusarova, M. S. Pantyushenko, V. M. Simonov, R. R. Shukurov, R. A. Khamitov, A. Yu. Vishnevskiy

Get full text

Development and certification of a pharmacopoeial reference standard for primary structure identification of purified recombinant interferon beta-1b by peptide mapping by E. O. Goloshchapova, O. B. Rounova, A. S. Minero, O. V. Fadeikina, R. A. Volkova, M. B. Degterev, S. A. Taran, R. R. Shukurov, O. B. Ustinnikova

Get full text